ESC 365 - SGLT2 inhibition across the spectrum of heart failure ‒ the evidence to date.

Open Access

SGLT2 inhibition across the spectrum of heart failure ‒ the evidence to date.

Session: Optimizing foundational therapies in patients with heart failure: from evidence to real-world clinical practice

Topic: Chronic Heart Failure

Speaker: Professor S. Anker (Berlin, DE)

Organised by Charité Friends & Sponsors Trust

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

171 presentations

11 followers

6 more presentations in this session

Welcome and introduction.

Speaker: Professor C. Lam (Singapore, SG)

Optimizing foundational therapies in clinical practice. The patient with HFpEF.

Speaker: Professor G. Savarese (Stockholm, SE)

The patient with HFrEF.

Speaker: Doctor S. Zieroth (Winnipeg, CA)

The patient hospitalized for HF.

Speaker: Professor P. Ponikowski (Wroclaw, PL)

Interactive panel discussion.

Speaker: Professor P. Ponikowski (Wroclaw, PL) Professor A. Stewart Coats (Sydney, AU) Professor S. Anker (Berlin, DE) Professor C. Fonseca (Lisbon, PT) Doctor S. Zieroth (Winnipeg, CA)

Access the full session

Optimizing foundational therapies in patients with heart failure: from evidence to real-world clinical practice

Speakers: Professor S. Anker, Professor C. Lam, Professor G. Savarese, Doctor S. Zieroth, Professor P. Ponikowski...

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources